12.2302.86% ( -0.360 )
已收盤: 11月16日 16:00:01 (美東)股東
全部股東
股東類型
- 創投/私募31.01%
- 公眾及其他24.99%
- 機構投資者20.21%
- 上市公司9.90%
- 其他13.89%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
Arch Venture Partners, L.P. | 12.91% | 375.49 萬 | -- | +375.49 萬 | |
OrbiMed Advisors LLC | 12.34% | 358.91 萬 | -- | +358.91 萬 | |
FMR LLC | 11.18% | 325.00 萬 | -- | +325.00 萬 | 30/10/2026 |
Gilead Sciences, Inc. | 9.90% | 288.00 萬 | -- | +288.00 萬 | 30/10/2026 |
Qatar Investment Authority | 6.65% | 193.33 萬 | -- | +193.33 萬 | 30/10/2026 |
Frazier Life Sciences Management, LP | 5.76% | 167.43 萬 | -- | +167.43 萬 | |
Q Healthcare Holding LLC | 4.59% | 133.33 萬 | -- | +133.33 萬 | 30/10/2026 |
Abu Dhabi Investment Authority | 4.46% | 129.69 萬 | -- | +129.69 萬 | 30/10/2026 |
Medical Excellence Capital, LLC | 3.71% | 107.85 萬 | -- | +107.85 萬 | 30/10/2026 |
Damien McDevittPresident, CEO & Director | 1.93% | 56.16 萬 | -- | +56.16 萬 | 30/10/2026 |
Axon Ventures | 0.86% | 25.04 萬 | -- | +25.04 萬 | |
Faheem HasnainExecutive Chairman | 0.22% | 6.30 萬 | -- | +6.30 萬 | |
Andrew SpaventaIndependent Director | 0.20% | 5.77 萬 | -- | +5.77 萬 | |
Thomas DanielIndependent Director | 0.12% | 3.51 萬 | -- | +3.51 萬 | 30/10/2026 |
Jon Spaventa | 0.07% | 2.02 萬 | -- | +2.02 萬 | 30/10/2026 |
Sharon Spaventa | 0.07% | 2.02 萬 | -- | +2.02 萬 | 30/10/2026 |
AG Artemis Holdings, L.P. | 0.05% | 1.33 萬 | -- | +1.33 萬 | 30/10/2026 |
Dalen MeeterChief Financial Officer | 0.00% | 0.00 | -- | +0 | 30/10/2026 |
Peter ThompsonIndependent Director | 0.00% | 0.00 | -- | +0 | 30/10/2026 |
Kim RaineriChief Technology Officer | 0.00% | 0.00 | -- | +0 | 30/10/2026 |
